During the past decade, Charlotte Hungerford Hospital Center for Cancer Care conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 13 clinical trials were completed, i.e. on average, 144.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charlotte Hungerford Hospital Center for Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Halozyme Therapeutics" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Charlotte Hungerford Hospital Center for Cancer Care" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Adult Cholangiocarcinoma" (1 trials), "Advanced Adult Hepatocellular Carcinoma" (1 trials) and "BCLC Stage C Adult Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Charlotte Hungerford Hospital Center for Cancer Care" in a lesser frequency.

Most popular intervention types in "Charlotte Hungerford Hospital Center for Cancer Care" are "Drug" (12 trials), "Other" (10 trials), "Biological" (6 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Docetaxel" (3 trials), "Dexamethasone" (2 trials), "Durvalumab" (2 trials) and "5-fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charlotte Hungerford Hospital Center for Cancer Care" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Charlotte Hungerford Hospital Center for Cancer Care". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Charlotte Hungerford Hospital Center for Cancer Care, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Charlotte Hungerford Hospital Center for Cancer Care, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".